Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Sartore-Bianchi, A."'
Autor:
Salvatore Siena, Eric Van Cutsem, Mingyu Li, Ulf Jungnelius, Alfredo Romano, Robert Beck, Katia Bencardino, Maria Elena Elez, Hans Prenen, Mireia Sanchis, Andrea Sartore-Bianchi, Sabine Tejpar, Anita Gandhi, Tao Shi, Josep Tabernero
Publikováno v:
PLoS ONE, Vol 8, Iss 11, p e62264 (2013)
This study aimed to assess the efficacy and safety of combination treatment with lenalidomide and cetuximab in KRAS-mutant metastatic colorectal cancer patients. This was a phase II multicenter, open-label trial comprising a safety lead-in phase (pha
Externí odkaz:
https://doaj.org/article/4a568ab78f1f4a15bc80d84a97ec5af2
Autor:
Andrea Sartore-Bianchi, Federica Di Nicolantonio, Michele Nichelatti, Francesca Molinari, Sara De Dosso, Piercarlo Saletti, Miriam Martini, Tiziana Cipani, Giovanna Marrapese, Luca Mazzucchelli, Simona Lamba, Silvio Veronese, Milo Frattini, Alberto Bardelli, Salvatore Siena
Publikováno v:
PLoS ONE, Vol 4, Iss 10, p e7287 (2009)
KRAS mutations occur in 35-45% of metastatic colorectal cancers (mCRC) and preclude responsiveness to EGFR-targeted therapy with cetuximab or panitumumab. However, less than 20% patients displaying wild-type KRAS tumors achieve objective response. Al
Externí odkaz:
https://doaj.org/article/e7cc86bb191241b9aba77e8b9592b4e7
Autor:
Sartore-Bianchi, Andrea1, Di Nicolantonio, Federica2, Nichelatti, Michele3, Molinari, Francesca4, Dosso, Sara De5, Saletti, Piercarlo5, Martini, Miriam2, Cipani, Tiziana1, Marrapese, Giovanna1, Mazzucchelli, Luca4, Lamba, Simona2, Veronese, Silvio6, Frattini, Milo4, Bardelli, Alberto2,7 a.bardelli@unito.it, Siena, Salvatore1 salvatore.siena@ospedaleniguarda.it
Publikováno v:
PLoS ONE. 2009, Vol. 4 Issue 10, p1-9. 9p. 3 Diagrams, 5 Charts, 3 Graphs.
Autor:
Siena, Salvatore, Van Cutsem, Eric, Li, Mingyu, Jungnelius, Ulf, Romano, Alfredo, Beck, Robert, Bencardino, Katia, Elez, Maria Elena, Prenen, Hans, Sanchis, Mireia, Sartore-Bianchi, Andrea, Tejpar, Sabine, Gandhi, Anita, Shi, Tao, Tabernero, Josep, Stemmer, Salomon M.
Publikováno v:
PLoS ONE, Vol 8, Iss 11, p e62264 (2013)
PLoS ONE
PLoS ONE
This study aimed to assess the efficacy and safety of combination treatment with lenalidomide and cetuximab in KRAS-mutant metastatic colorectal cancer patients. This was a phase II multicenter, open-label trial comprising a safety lead-in phase (pha
Autor:
Siena, Salvatore, Van Cutsem, Eric, Li, Mingyu, Jungnelius, Ulf, Romano, Alfredo, Beck, Robert, Bencardino, Katia, Elez, Maria Elena, Prenen, Hans, Sanchis, Mireia, Sartore-Bianchi, Andrea, Tejpar, Sabine, Gandhi, Anita, Shi, Tao, Tabernero, Josep
Publikováno v:
PLoS ONE; Nov2013, Vol. 8 Issue 11, p1-9, 9p